Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Cassidy

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Scientific Reports|October 3, 2023
Functional consequences of A-to-I editing of miR-379 in prostate cancer cellsGjendine Voss, James R Cassidy, Yvonne Ceder
Frontiers in Oncology|October 2, 2023
Expression of microRNA-379 reduces metastatic spread of prostate cancerJames R Cassidy, Gjendine Voss, Kira Rosenkilde Underbjerg, et al.
Cancers|October 16, 2025
MicroRNA-379 Modulates Prostate-Specific Antigen Expression Through Targeting the Androgen Receptor in Prostate CancerJames R Cassidy, Margareta Persson, Gjendine Voss, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Scientific Reports|October 3, 2023
Functional consequences of A-to-I editing of miR-379 in prostate cancer cellsGjendine Voss, James R Cassidy, Yvonne Ceder
Frontiers in Oncology|October 2, 2023
Expression of microRNA-379 reduces metastatic spread of prostate cancerJames R Cassidy, Gjendine Voss, Kira Rosenkilde Underbjerg, et al.
Cancers|October 16, 2025
MicroRNA-379 Modulates Prostate-Specific Antigen Expression Through Targeting the Androgen Receptor in Prostate CancerJames R Cassidy, Margareta Persson, Gjendine Voss, et al.
Pageof 1